Connect your AI

HNGE HNGE Amortized cost of available-for-sale debt securities, current

Amortized cost of available-for-sale debt securities, current at other companies

Globus MedicalGMED

——

Hims & Hers HealthHIMS

——

Other financials

Income statement

Revenue$182.3M+47.2%

Gross profit$154.2M+53.9%

Operating income$32.1M+144%

Net income$35.1M+105%

EPS (diluted)$0.41-68.7%

Balance sheet

Cash & equivalents$188.1M-35.2%

Total debt$7.0M—

Total equity$111.7M+136%

Total assets$728.8M—

Cash flow

Operating cash flow$43.1M+775%

CapEx$83.0K+62.7%

Free cash flow$43.0M+782%

Valuation

Market cap$5.37B—

Enterprise value$5.19B—

P/S8.3×—

Profitability

Gross margin80.8%+1.5pp

Operating margin-85.8%—

Net margin-83.9%—

FCF margin32.3%—

Returns & leverage

Return on equity551.8%—

Debt / equity0.1×—

Current ratio1.3×—

Where this comes from

Reported directly by HNGE in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent.

The official record: HNGE’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about HNGE's amortized cost of available-for-sale debt securities, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is HNGE's amortized cost of available-for-sale debt securities, current?: HNGE (HNGE) reported amortized cost of available-for-sale debt securities, current of $129.27M in Q1 2026.